■本系统综述旨在严格评估富含血小板的纤维蛋白对上颌窦底增强的影响,并概述新骨形成的具体方面,骨高度,植入物稳定性商,和施耐德膜厚度。
■进行了系统评价和荟萃分析,分析来自MEDLINE(PubMed)的研究,Cochrane图书馆,和ScienceDirect数据库,发表于2018年1月29日至2024年1月29日,比较了使用带有和不带有富血小板纤维蛋白(PRF)的植骨材料的上颌窦底增强(MSFA)。这篇综述的重点是18岁及以上在植入牙之前接受MSFA的患者。它系统地研究了五项研究,包括随机对照试验,并报告了84例患者进行的112例MSFA手术。
■荟萃分析揭示了PRF在新骨形成中的边缘意义,提示有益结果的趋势,但没有统计学意义。未观察到对骨高度的显著影响。然而,记录到植入物稳定性商(ISQ)的显着改善,表明PRF增强了植入物的稳定性。施耐德膜厚度在用PRF处理后未显示显著变化。
■虽然富含血小板的纤维蛋白显示出增强植入物稳定性的前景,它对新骨形成和Schneiderian膜厚度的影响尚无定论,强调需要进一步研究。富含血小板的纤维蛋白对骨骼高度没有显着影响。这些发现支持富含血小板的纤维蛋白作为上颌窦底扩张术的有益辅助手段的潜力,特别是植入物的稳定性。
UNASSIGNED: This systematic review aims to critically assess the impact of platelet-rich fibrin on maxillary sinus floor augmentation and outline the specific aspects of new bone formation, bone height, implant stability quotient, and Schneiderian membrane thickness.
UNASSIGNED: A systematic review and meta-analysis were conducted, analysing studies from MEDLINE (PubMed), the Cochrane Library, and ScienceDirect databases, published from January 29, 2018 until January 29, 2024 that compared maxillary sinus floor augmentation (MSFA) using bone graft material with and without platelet-rich fibrin (PRF). This review focused on patients 18 years and older who undergone MSFA before the dental implant placement. It systematically examined five studies, encompassing randomized controlled trials, and reported on 112 MSFA procedures conducted in 84 patients.
UNASSIGNED: The meta-analysis reveals a marginal significance in new bone formation with PRF, suggesting a trend towards beneficial outcomes that were not statistically significant. No significant impact on bone height was observed. However, a notable improvement in implant stability quotient (ISQ) was recorded, indicating enhanced implant stability with PRF. The Schneiderian membrane thickness did not show significant changes post-treatment with PRF.
UNASSIGNED: While platelet-rich fibrin shows promise in enhancing implant stability, its effects on new bone formation and Schneiderian membrane thickness are inconclusive, highlighting the need for further research. Platelet-rich fibrin did not significantly affect bone height. The findings support platelet-rich fibrin\'s potential as a beneficial adjunct in maxillary sinus floor augmentation, particularly for implant stability.